News & Events
2022-11-14
Turning Philanthropy into PV Power | EGING PV Donated to Cancer Research Institute in Saint Anna Children’s Hospital
Days ago, the Austrian PV Company Energy3000 Solar successfully hosted the 12. Burgenl?ndische Tafelrunde, to which EGING PV was also invited as the senior partner of Energy3000 Solar. At the Charity Party, a special session in the event, EGING PV generously donated money and a batch of modules to the Cancer Research Institute of Saint Anna Children’s Hospital.
Burgenl?ndische Tafelrunde, hosted by Energy3000 Solar, has become a gathering of customers and partners in the industry. It is now a featured annual event of Energy3000 Solar. The 12th session, now the largest one of its kind so far, receives more than 360 participants and lasts three days. This year, Energy3000 Solar released the latest digital tool and service solarJet at the event site and shared the latest trends in the industry.
Over the years, Energy3000 has continued to make contributions to charity. This year, it planned lottery-draw activity for the Cancer Research Institute of Saint Anna Children's Hospital and invited partners to donate. EGING PV responded positively and made donations in the form of cash and modules, thus contributing to the Cancer Research Institute of Saint Anna Children’s Hospital, turning philanthropy into PV power, and sending warmth and hope to children.
Adhering to the spirit of “diligence, honesty, ambition, and accessibility for the future of PV”, EGING PV takes its mission to “provide the most reliable clean energy”, creates more values for all communities, always keeps in mind its original aspiration and delivers philanthropy of China to the world.
Company News

EGING PV Ranked Among Top 3 Module Suppliers to Brazilian Market in Latest Greener Report

EGING PV Shines at China-Arab Expo: Aurora Pro and Star Pro Series Lead Green Energy Cooperation

EGING PV Leads Imports in the First Half of the Year and Showcases New Modules at Intersolar South America 2025

Eging PV Technology R&D Center Laboratory Successfully Passes CNAS Reassessment






